King Luther Capital Management Corp Sells 390 Shares of Axon Enterprise, Inc $AXON

King Luther Capital Management Corp lessened its position in Axon Enterprise, Inc (NASDAQ:AXON) by 7.3% during the 2nd quarter, Holdings Channel reports. The firm owned 4,953 shares of the biotechnology company’s stock after selling 390 shares during the quarter. King Luther Capital Management Corp’s holdings in Axon Enterprise were worth $4,101,000 at the end of the most recent reporting period.

A number of other large investors have also bought and sold shares of the business. TCTC Holdings LLC grew its holdings in shares of Axon Enterprise by 75.0% during the first quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company’s stock worth $29,000 after purchasing an additional 24 shares during the last quarter. Banque Transatlantique SA bought a new stake in shares of Axon Enterprise during the first quarter worth approximately $31,000. Flaharty Asset Management LLC acquired a new position in shares of Axon Enterprise in the 1st quarter valued at $33,000. Hemington Wealth Management boosted its holdings in Axon Enterprise by 70.8% during the second quarter. Hemington Wealth Management now owns 41 shares of the biotechnology company’s stock worth $33,000 after buying an additional 17 shares during the last quarter. Finally, Whipplewood Advisors LLC boosted its stake in Axon Enterprise by 192.9% during the 2nd quarter. Whipplewood Advisors LLC now owns 41 shares of the biotechnology company’s stock worth $34,000 after acquiring an additional 27 shares during the last quarter. 79.08% of the stock is currently owned by institutional investors.

Axon Enterprise Trading Down 3.0%

Shares of Axon Enterprise stock opened at $584.69 on Tuesday. The company has a quick ratio of 2.71, a current ratio of 2.95 and a debt-to-equity ratio of 0.63. The company has a market capitalization of $46.14 billion, a price-to-earnings ratio of 144.37, a PEG ratio of 29.49 and a beta of 1.45. The firm’s 50-day moving average price is $716.36 and its two-hundred day moving average price is $737.12. Axon Enterprise, Inc has a 12-month low of $469.24 and a 12-month high of $885.91.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings data on Tuesday, November 4th. The biotechnology company reported $1.17 EPS for the quarter, missing the consensus estimate of $1.63 by ($0.46). Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. The firm had revenue of $710.64 million for the quarter, compared to analyst estimates of $704.83 million. During the same quarter in the prior year, the firm earned $1.45 earnings per share. The firm’s revenue for the quarter was up 30.6% on a year-over-year basis. Axon Enterprise has set its Q4 2025 guidance at EPS. FY 2025 guidance at EPS. On average, analysts forecast that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

Insider Transactions at Axon Enterprise

In other news, CEO Patrick W. Smith sold 10,000 shares of Axon Enterprise stock in a transaction dated Tuesday, October 7th. The stock was sold at an average price of $713.74, for a total transaction of $7,137,400.00. Following the sale, the chief executive officer directly owned 3,033,982 shares of the company’s stock, valued at approximately $2,165,474,312.68. This trade represents a 0.33% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, President Joshua Isner sold 15,919 shares of the business’s stock in a transaction that occurred on Friday, August 15th. The stock was sold at an average price of $746.26, for a total transaction of $11,879,712.94. Following the sale, the president directly owned 238,379 shares in the company, valued at $177,892,712.54. The trade was a 6.26% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 49,932 shares of company stock valued at $36,802,716. 4.40% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several brokerages recently commented on AXON. Cowen reaffirmed a “buy” rating on shares of Axon Enterprise in a research note on Wednesday, November 5th. Barclays lowered their price target on shares of Axon Enterprise from $861.00 to $702.00 and set an “overweight” rating on the stock in a research note on Thursday, November 6th. Weiss Ratings restated a “hold (c)” rating on shares of Axon Enterprise in a research note on Wednesday, October 8th. Craig Hallum raised shares of Axon Enterprise from a “hold” rating to a “buy” rating and set a $900.00 target price on the stock in a report on Tuesday, August 5th. Finally, UBS Group reduced their price objective on shares of Axon Enterprise from $840.00 to $610.00 and set a “neutral” rating for the company in a research report on Wednesday, November 5th. Fourteen investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat, Axon Enterprise presently has an average rating of “Moderate Buy” and a consensus price target of $810.71.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.